Clariane studies knee-raise test to screen for sarcopenia
Clariane is studying a knee-raise test for sarcopenia screening in 63 older patients.
Related stories
China Nuclear Engineering Q3 Net Profit Falls 27.68% YoY
M impact | EQUITY | Oct 29, 2026, 01:58 PM UTC
Jerusalem Insurance Reports Q3 Profit After Tax of 2.7 Million Dinars
M impact | EQUITY | Oct 29, 2026, 01:54 PM UTC
Integer Reports Fiscal Q3 Adjusted Earnings and Sales Decline
Integer reported declines in fiscal Q3 adjusted earnings and sales.
M impact | EQUITY | Oct 29, 2026, 01:54 PM UTC
Lygend Resources Reports Quarterly Revenue of RMB 12,124.2 Million
M impact | EQUITY | Oct 29, 2026, 01:54 PM UTC
Indivior Shares Rise After Q3 Adjusted EPS and Revenue Top Estimates
Indivior shares were up more than 4% after the company’s Q3 adjusted EPS and revenue topped estimates.
M impact | EQUITY | Oct 29, 2026, 01:54 PM UTC
CSW Industrials Shares Rise After Fiscal Q2 Results Surpass Consensus
CSW Industrials shares were up 1.4% after the open following fiscal Q2 adjusted net income and revenue that surpassed consensus.
M impact | EQUITY | Oct 29, 2026, 01:53 PM UTC